Freedman Joseph S.

13D and 13G Filings

13D/G filings
13D on 1 security
CIK
0002043590
All SEC filings
View on sec.gov
Issuer % of Class Filed
Eupraxia Pharmaceuticals Inc. 13D/A Amendment 2
EPRX · 29842P105
9.0% 3/16/2026
Event 3/13/2026
Eupraxia Pharmaceuticals Inc. 13D/A Amendment 1
EPRX · 29842P105
10.2% 9/26/2025
Event 9/24/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.